文献速递冠心病外科心外重症与机械循环支持

Impella在梗死后室间隔缺损术前管理中的作用:系统综述

The role of Impella in the pre-procedural management of post-infarct ventricular septal defect: a systematic review.
PubMed 文献 · Interdiscip Cardiovasc Thorac Surg · 2024-01-01

本系统综述评估Impella在梗死后室间隔缺损患者术前过渡治疗中的结局。纳入20篇文献共68例患者,超过95%在植入时处于心源性休克,总住院死亡率47%,观察到29例Impella相关并发症。手术植入者住院死亡率(35%)数值上低于经皮植入者(58%)。

要点

  • Impella可用于梗死后室间隔缺损合并心源性休克患者的术前稳定。
  • 总住院死亡率为47%,手术植入者死亡率数值上低于经皮植入者。
  • 需警惕Impella相关并发症,共观察到29例。

核心结论

  • Impella可有效减少低心排综合征、改善外周灌注并卸载心室,但相关并发症需被考虑。

研究设计与样本

  • 系统综述,遵循PRISMA标准,检索Medline和EMBASE数据库,纳入20篇文献共68例患者。

主要发现

  • 超过95%的患者在植入Impella时处于心源性休克,一半患者使用了另一种机械循环支持装置。
  • 62%的患者为后壁缺损,72%接受了外科或经皮修复。
  • 总住院死亡率为47%,共观察到29例Impella相关并发症。
  • 手术植入Impella的患者住院死亡率(35% vs. 58%)和并发症发生率数值上低于经皮装置。

临床怎么用

  • Impella可作为其他机械循环支持的升级或体外膜氧合的补充,提供左心室或双心室支持。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Post-infarct ventricular septal defect is a rare but devastating complication. Delayed treatment offers better outcomes than emergency surgery, but when acute cardiogenic shock or unstable haemodynamics occur, temporary mechanical circulatory support may be needed to stabilize patients until treatment. The aim of our systematic review was to assess the outcomes of using Impella in this setting. METHODS: A systematic search was performed in the Medline and EMBASE databases, and all the papers about the use of Impella in this setting were assessed. The study followed the PRISMA criteria. RESULTS: A total of 20 papers encompassing 68 patients with an Impella implanted after the diagnosis of post-infarct ventricular septal defect and before its treatment were included. More than 95% were in cardiogenic shock when Impella was implanted, and half had another mechanical circulatory support device. Most of the patients (62%) had a posterior defect, and 72% underwent surgical or percutaneous repair. Total in-hospital mortality was 47%, and a total of 29 Impella-related complications were observed. Patients with surgical Impella had a numerically lower in-hospital mortality (35% vs. 58%) and a lower rate of complications compared to percutaneous device. CONCLUSIONS: Impella represents an effective device for diminishing low output syndrome, improving peripheral perfusion, and unloading both the ventricles. It can be used as an upgrade from another mechanical circulatory support or as an addition to extracorporeal membrane oxygenation to provide adequate left ventricular or biventricular support. Despite this, Impella-related complications can occur after its implantation and must be considered.

来源:Interdiscip Cardiovasc Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Gemelli M, Ronco D, Di Mauro M, et al. The role of Impella in the pre-procedural management of post-infarct ventricular septal defect: a systematic review. Interdiscip Cardiovasc Thorac Surg. 2024. PMID: 39673774. doi:10.1093/icvts/ivae212

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。